58 filings
Page 3 of 3
8-K
kqk09qo
17 Mar 21
Axcella Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
7:44am
8-K
aprek 67b109b0
3 Mar 21
Axcella Announces Alison D. Schecter, M.D., as President of R&D
5:26pm
8-K
s6e208 p8g2z673v4y
12 Nov 20
Axcella Reports Third Quarter 2020 Financial Results and Provides Business Update
7:47am
8-K
2q7bn
31 Aug 20
Entry into a Material Definitive Agreement
9:00am
8-K
tdqyg 61db
5 Aug 20
Axcella Reports Positive Top-Line Data from AXA1665-002 and Second Quarter Financial Results
8:22am
8-K
oq351 3hd24se5
20 May 20
Departure of Directors or Certain Officers
4:05pm
8-K
o56vcow80nqtptt4
18 May 20
Axcella Announces Pricing of Public Offering of Common Stock
4:17pm
8-K
rhyv ozu3suo4wn88i7i
11 May 20
Axcella Reports First Quarter Financial Results and Provides Business Update
8:13am
8-K
z22gq2i
8 May 20
Amendments to Articles of Incorporation or Bylaws
4:06pm
8-K
ykw eam0h
6 May 20
Axcella Announces Positive Top-Line Data from AXA1125-003 Clinical Study Showing Multifactorial Activity in Adult Subjects with NAFLD
8:09am
8-K
c9e82gd1m5ac5gx r7pe
23 Mar 20
Axcella Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
4:03pm
8-K
8bf 9a1r6ds0
25 Nov 19
Axcella Strengthens Executive Team with Key Addition and Promotion
8:11am
8-K
vvc3kea3v
12 Nov 19
Results of Operations and Financial Condition
4:04pm
8-K
uovqa 7d4jp7fjnia67t
8 Nov 19
Departure of Directors or Certain Officers
4:08pm
8-K
lssu7 nlp
23 Aug 19
Entry into a Material Definitive Agreement
4:18pm
8-K
wii3i6ubrv10c99teyj
12 Aug 19
Results of Operations and Financial Condition
4:50pm
8-K
kerjuja1qspcx9twh ng
20 Jun 19
Results of Operations and Financial Condition
4:44pm
8-K
332nhc3zv2b77j0
17 May 19
Amendments to Articles of Incorporation or Bylaws
4:07pm